Vyome Holdings HIND
NASDAQ HIND
$2.06 -0.03 (-1.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vyome Holdings (HIND) Market Capitalization (2025 - 2026)

Vyome Holdings (HIND) posted Market Capitalization of $15.1 million for Q2 2026, little changed on a QoQ basis from $15.1 million in Q1 2026.

Analysis

Vyome Holdings (HIND) Market Capitalization (2025 - 2026) Analysis & Trends

Vyome Holdings has reported Market Capitalization for 2 years, with the latest figure at $15.1 million in Q2 2026.

  • On a quarterly basis, Market Capitalization changed N/A year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.4 million, changed N/A from the prior year.
  • Market Capitalization was $15.1 million for Q2 2026 at Vyome Holdings, roughly flat from $15.1 million in the prior quarter.
  • The five-year high for Market Capitalization was $15.1 million in Q1 2026, with the low at $7.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Vyome Holdings 14.46 Mn 6.57 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.09 Mn
Mar 31, 2026 15.09 Mn
Dec 31, 2025 7.44 Mn
Sep 30, 2025 14.29 Mn